Te-Lin Hsu, Chun-Kuang Tsai, Chun-Yu Liu, Chiu-Mei Yeh, Fen-Lan Lin, Liang-Tsai Hsiao, Yao-Chung Liu, Sheng-Hsuan Chien, Hao-Yuan Wang, Po-Shen Ko, Ting-An Lin, Wen-Chun Chen, Po-Min Chen, Jin-Hwang Liu, Jyh-Pyng Gau, Chia-Jen Liu
Multiple myeloma (MM) stands as the second most prevalent hematological malignancy, constituting approximately 10% of all hematological malignancies. Current guidelines recommend upfront autologous stem cell transplantation (ASCT) for transplant-eligible MM patients. This study seeks to delineate factors influencing post-ASCT outcomes in MM patients. Our cohort comprised 150 MM patients from Taipei Veterans General Hospital, with progression-free survival (PFS) as the primary endpoint and overall survival (OS) as the secondary endpoint...
March 13, 2024: Annals of Hematology